1. Peterson C. T., Sharma V., Elmén L., Peterson S. N. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clinical and Experimental Immunology 2015, 179(3), 363–377.
2. Gonçalves P., Araújo J. R., Di Santo J. P. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Infl ammatory Bowel Disease. Infl amm. Bowel Dis. 2018, 24(3), 558–572
3. Asquith M., Elewaut D., Lin P., Rosenbaum J. T. The role of gut and microbes in the pathogenesis of spondyloarthritis. Best Pract Res Clin Rheumatol. 2014, 28(5), 687–702.
4. Simbirtsev A. S. Cytokines in the pathogenesis and treatment of human diseases. Foliant, St. Petersburg, 2018, 512 p.
5. Hoeppli R. E., Wu D., Cook L., Levings M. K. The Environment of Regulatory T Cell Biology: Cytokines, Metabolites, and the Microbiome. Front Immunol. 2015, 6: 61. doi: 10.3389/fi mmu.2015.00061.
6. Wilson M., Seymour R., Henderson B. Bacterial perturbation of Cytokine Networks. Infect. Immun. 1998, 66 (6), 2401–2409.
7. Potempa J., Pike R. N. Corruption of Innate Immunity by Bacterial Proteases. J. Innate Immun. 2009, 1 (2): 70–87
8. Bukharin O. V., Perunova N. B., Chainikova I. N., Ivanova E. V., Smolyagin A. I. Anti-cytokine activity of microorganisms. Journ. Microbiol. 2011, 4, 56–61
9. Ma N., Guo P., Zhang J., He T., Kim S. W., Zhang G., Ma X. Nutrients Mediate Intestinal Bacteria–Mucosal Immune Crosstalk. Frontiers in Immunology, 2018, 9, 5. http://doi.org/10.3389/fi  mmu.2018.00005